The FDA has cleared Covidien‘s Puritan Bennett 980 Ventilator for use with neonatal patients, children, and adults. The device features Proportional Assist Ventilation Plus (PAV+) technology licensed from University of Manitoba in Canada that provides smarter pumping to optimally synchronize with every patient. This will hopefully allow many patients to get off the ventilator earlier, something studies of proportional-assist ventilation have already indicated.
“We believe mechanical ventilation should be natural enough to enable patients to breathe on their own more quickly,” said James E. Willett, vice president and general manager, Respiratory Solutions, Covidien. “The Puritan Bennett 980 ventilator provides clinicians with a simple, safe and smart way to care for patients.”